General Meeting of Shareholders No. 2/2018, held on 19 June 2018, resolved to cancel the approval on the disposal of the asset under Agenda 3 of the Extraordinary General Meeting of Shareholders No. 1/2018
transaction size together with the Company’s other acquisition transactions within the past 6 months prior to the approval of the Board of Directors as mentioned above, which is 18.49 percent as calculated
’ Meeting No.1/2018 held on 21 February 2018.There is the approval of investment for the new Hospital at Suratthani under the name of “Wattanapat Samui Hospital” (Wattanapat Samui Hospital Project) which is
approval of the acquisition from the Comapany’s Board of Director No. 5/2017 held on 31 October 2017. The Share Purchase Agreement will be effective after Board of Director’s approval. 2) Related Contract
February 2018.There is the approval of investment for the new Hospital at Suratthani under the name of “Wattanapat Samui Hospital” (Wattanapat Samui Hospital Project) which is involved in the transaction to
extraordinary general meeting of shareholders on November 21, 2017 for consideration and approval of the capital increase of a number of 100 million shares by right offering (RO) to existing shareholders at a
been granted prior approval by the authorized Committee or management concerned; (c) number of persons and information of the personnel who are responsible for risk management arising from derivatives
been granted prior approval by the authorized Committee or management concerned; (Translation) (c) number of persons and information of the personnel who are responsible for risk management arising from
professional in accounting, finance, business administration, economics or law; Clause 2. The person with power of management of the derivatives business operator must obtain approval from the SEC Office. Clause